|
3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine Suppliers list
|
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | 3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine Basic information |
| Product Name: | 3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine | | Synonyms: | 3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine;3-((3S,8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine;Acetic acid abiolone impurity 11;Pyridine, 3-(3-chloroandrosta-5,16-dien-17-yl)-;Abiraterone Impurity O;Abiraterone acetate USP Impurity G;3-((8R,9S,10R,13S,14S)-3-Chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine (Abiraterone impurity) | | CAS: | 2484719-16-4 | | MF: | C24H30ClN | | MW: | 367.96 | | EINECS: | | | Product Categories: | | | Mol File: | 2484719-16-4.mol | ![3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine Structure](CAS/20210305/GIF/2484719-16-4.gif) |
| | 3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine Chemical Properties |
| Boiling point | 495.4±45.0 °C(Predicted) | | density | 1.15±0.1 g/cm3(Predicted) | | solubility | Chloroform (Slightly), DMSO (Slightly, Heated) | | pka | 5.31±0.12(Predicted) | | form | Solid | | color | Off-White to Pale Yellow |
| | 3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine Usage And Synthesis |
| Uses | 3-Deoxy-3S-chloroabiraterone is an impurtiy of Abiraterone (A108490), which is a steroidal cytochrome P 450 17a-hydroxylase-17,20-lyase inhibitor (CYP17) and is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| | 3-((8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine Preparation Products And Raw materials |
|